Navigate Up
Sign In

Newsletter Subcommittee

The Newsletter Subcommittee publishes the AIPLA Chemical Practice Chronicles, which is the Newsletter of the AIPLA Chemical Practice Committee

Newsletter Subcommittee Chairs
Perry + Currier Inc., Currier + Kao LLP

Fay Kaplun & Marcin, LLP​

Jill A. Hecht​
University of Houston Law Center​


This is a call for submissions for the 2018 Fall Chemical Practice Committee Newsletter to be published on or about October 1, 2018. 

We are looking for news and information concerning upcoming events, summaries of legal decisions, articles, and any other information that may be relevant to our committee members, as well as suggestions for topics for articles. Please send your suggestions and/or contributions to Dolly Kao (; +1 (416) 509-7447) by no later than ***September 5, 2018***

If you have any questions, please contact Dolly Kao and/or Jenny Lee (; 212-619-6000, ext. 205).

Our Spring 2018 of the AIPLA Chemical Practice Chronicles is now available.

Articles and Case Law
Decisions Relating to the Question of Whether or Not Obviousness Double Patenting Can Be Used to Take Away Patent Term Extension in the U.S. 

Executive Summary of Recent Lead Compound Cases: Mylan Pharm. Inc. v. Astrazeneca AB., Case IPR2015-01340 (PTAB 2017) and Millennium Pharm., Inc. v. Sandoz Inc., 862 F.3d 1356 (Fed. Cir. 2017)
Jill A. Hecht​

Patent Trial and Appeal Board Applies Obviousness Analysis: Mylan Pharm. Inc. v. Astrazeneca AB., Case IPR2015-01340 (PTAB 2017)
Jill A. Hecht​

Federal Circuit Refines Obviousness Analysis: Millennium Pharm., Inc. v. Sandoz Inc., 862 F.3d 1356 (Fed. Cir. 2017)
Jorge Zamora​ and Jill A. Hecht​​

International Focus
Patent term adjustment for pharmaceuticals in Latin America: A special reference to the case of Chile

Canada’s Supreme Court Abolishes Controversial “Promise Doctrine”

AIPLA Chemical Practice Chronicles Archive